Found 107 matching trials
Temozolomide Alone or With Pegylated Interferon-Alpha 2b (PGI) in Melanoma Patients
PHASE2The goal of this clinical research study is to learn if temozolomide alone ...
Location
University of Texas MD Anderson Cancer Center
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
PHASE2This study will address the question of whether targeting CMV antigens with...
Location
Children's Hospital Colorado
Stupp Treatment With Intrathecal Injection of Thiotepa for Glioblastoma With Advanced Spread
PHASE2The goal of this clinical trial is to learn if a combined treatment approac...
Location
2nd Affiliated Hospital, School of Medicine
Dendritic Cell-Based Tumor Vaccine Adjuvant Immunotherapy of Human Glioblastoma Multiforme (WHO Grade IV Gliomas)
PHASE2Purposes:
The purpose of this phase-II clinical trial is to determine whet...
Location
China Medical University Hospital
Combination of Lanreotide Autogel 120mg and Temozolomide in Progressive GEP-NET
PHASE2The purpose of the study is to evaluate the efficacy and tolerability of th...
Location
Vienna General Hospital
Survivin-Targeted Dendritic Cell (DC) Cell Injection for Newly Diagnosed Glioblastoma
PHASE2The overall objective of this study is to preliminarily evaluate the effica...
Location
Multiple Locations
N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma
PHASE2The purpose of this study is to find out whether N10 chemotherapy is a safe...
Location
Memorial Sloan Kettering Cancer Center
Abraxane and Temodar Plus Genasense in Advanced Melanoma
PHASE1This study is designed to evaluate the safety, efficacy, pharmacokinetics, ...
Location
New York University Cancer Center
Hyperpolarized Carbon-13 (13C) Pyruvate Imaging in Patients With Glioblastoma
PHASE1The purpose of this study is to evaluate whether new metabolic imaging will...
Location
University of California, San Francisco
A Two-part Phase IIb Trial of Vigil (Bi-shRNAfurin and GMCSF Augmented Autologous Tumor Cell Immunotherapy) in Ewing's Sarcoma
PHASE2A two-part trial in patients with metastic Ewing's sarcoma. Participants in...
Location
Arkansas Children's Hospital